Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
Irritable bowel syndrome (IBS) is a highly prevalent disorder of gut–brain interaction and poses a significant burden to patients. Pharmacotherapy, diet, and psychotherapy all have largely comparable clinical efficacy. Therefore, factors outside efficacy can have an important impact in determining p...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-12-01
|
| Series: | Journal of Patient Experience |
| Online Access: | https://doi.org/10.1177/23743735221147762 |
| _version_ | 1797976650720215040 |
|---|---|
| author | Rosel Sturkenboom MD, PhD Brigitte A B Essers PhD Ad A M Masclee MD, PhD Daniel Keszthelyi MD, PhD |
| author_facet | Rosel Sturkenboom MD, PhD Brigitte A B Essers PhD Ad A M Masclee MD, PhD Daniel Keszthelyi MD, PhD |
| author_sort | Rosel Sturkenboom MD, PhD |
| collection | DOAJ |
| description | Irritable bowel syndrome (IBS) is a highly prevalent disorder of gut–brain interaction and poses a significant burden to patients. Pharmacotherapy, diet, and psychotherapy all have largely comparable clinical efficacy. Therefore, factors outside efficacy can have an important impact in determining preferences for a specific therapeutic entity. The aim of this study was to compare the patient and physician perspectives and identify important treatment characteristics regarding the management of IBS. Semistructured interviews were performed among IBS patients (n = 8), fulfilling the Rome IV criteria, and surveys were sent to physicians involved in IBS care (n = 15). Nine important treatment characteristics were revealed: effectiveness, time until response, cessation of response, side effects, location, waiting period, treatment burden, frequency of healthcare appointments, and willingness to pay. Time to response, location, and waiting time were less important for patients compared to physicians. This study assessed important IBS treatment characteristics and provided context to preferences from a patient and physician perspective. These data could be relevant during shared decision-making in clinical practice. |
| first_indexed | 2024-04-11T04:55:23Z |
| format | Article |
| id | doaj.art-53744516b9f841839869ff7ec52afca8 |
| institution | Directory Open Access Journal |
| issn | 2374-3743 |
| language | English |
| last_indexed | 2024-04-11T04:55:23Z |
| publishDate | 2022-12-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of Patient Experience |
| spelling | doaj.art-53744516b9f841839869ff7ec52afca82022-12-26T15:35:07ZengSAGE PublishingJournal of Patient Experience2374-37432022-12-01910.1177/23743735221147762Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?Rosel Sturkenboom MD, PhD0Brigitte A B Essers PhD1Ad A M Masclee MD, PhD2Daniel Keszthelyi MD, PhD3 Department of Clinical Epidemiology and Medical Technology Assessment, CAPHRI Care and Public Health Research Institute, Maastricht University Medical Center, Maastricht, the Netherlands Department of Clinical Epidemiology and Medical Technology Assessment, CAPHRI Care and Public Health Research Institute, Maastricht University Medical Center, Maastricht, the Netherlands Division of Gastroenterology and Hepatology, Department of Internal Medicine, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands Division of Gastroenterology and Hepatology, Department of Internal Medicine, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the NetherlandsIrritable bowel syndrome (IBS) is a highly prevalent disorder of gut–brain interaction and poses a significant burden to patients. Pharmacotherapy, diet, and psychotherapy all have largely comparable clinical efficacy. Therefore, factors outside efficacy can have an important impact in determining preferences for a specific therapeutic entity. The aim of this study was to compare the patient and physician perspectives and identify important treatment characteristics regarding the management of IBS. Semistructured interviews were performed among IBS patients (n = 8), fulfilling the Rome IV criteria, and surveys were sent to physicians involved in IBS care (n = 15). Nine important treatment characteristics were revealed: effectiveness, time until response, cessation of response, side effects, location, waiting period, treatment burden, frequency of healthcare appointments, and willingness to pay. Time to response, location, and waiting time were less important for patients compared to physicians. This study assessed important IBS treatment characteristics and provided context to preferences from a patient and physician perspective. These data could be relevant during shared decision-making in clinical practice.https://doi.org/10.1177/23743735221147762 |
| spellingShingle | Rosel Sturkenboom MD, PhD Brigitte A B Essers PhD Ad A M Masclee MD, PhD Daniel Keszthelyi MD, PhD Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment? Journal of Patient Experience |
| title | Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment? |
| title_full | Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment? |
| title_fullStr | Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment? |
| title_full_unstemmed | Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment? |
| title_short | Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment? |
| title_sort | do patients and physicians perspectives differ on preferences for irritable bowel syndrome treatment |
| url | https://doi.org/10.1177/23743735221147762 |
| work_keys_str_mv | AT roselsturkenboommdphd dopatientsandphysiciansperspectivesdifferonpreferencesforirritablebowelsyndrometreatment AT brigitteabessersphd dopatientsandphysiciansperspectivesdifferonpreferencesforirritablebowelsyndrometreatment AT adammascleemdphd dopatientsandphysiciansperspectivesdifferonpreferencesforirritablebowelsyndrometreatment AT danielkeszthelyimdphd dopatientsandphysiciansperspectivesdifferonpreferencesforirritablebowelsyndrometreatment |